Last reviewed · How we verify
[89Zr]Zr-DFO-BIIB080
[89Zr]Zr-DFO-BIIB080 is a Small molecule drug developed by Biogen. It is currently in Phase 1 development.
At a glance
| Generic name | [89Zr]Zr-DFO-BIIB080 |
|---|---|
| Sponsor | Biogen |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [89Zr]Zr-DFO-BIIB080 CI brief — competitive landscape report
- [89Zr]Zr-DFO-BIIB080 updates RSS · CI watch RSS
- Biogen portfolio CI
Frequently asked questions about [89Zr]Zr-DFO-BIIB080
What is [89Zr]Zr-DFO-BIIB080?
[89Zr]Zr-DFO-BIIB080 is a Small molecule drug developed by Biogen.
Who makes [89Zr]Zr-DFO-BIIB080?
[89Zr]Zr-DFO-BIIB080 is developed by Biogen (see full Biogen pipeline at /company/biogen).
What development phase is [89Zr]Zr-DFO-BIIB080 in?
[89Zr]Zr-DFO-BIIB080 is in Phase 1.
Related
- Manufacturer: Biogen — full pipeline
- Compare: [89Zr]Zr-DFO-BIIB080 vs similar drugs
- Pricing: [89Zr]Zr-DFO-BIIB080 cost, discount & access